What should the ideal service for complex and severe obesity look like?

Tuesday 7th December 2021, 19.00 - 20.00

Severe and complex obesity generally refers to people with a BMI> 40 or those with a BMI > 35 kg / m2 and significant complications. Services to support people with severe and complex obesity exist to provide medical care and support together with multicomponent lifestyle interventions, appropriate use of pharmacotherapy and bariatric surgery. These have gradually developed in the UK over the last 20-25 years and are termed by the NHS as tier 3 (medical weight management) and tier 4 (surgical weight management). Despite a significant need, surveys suggest that only about 2/3 of the population in England have access to any sort of service, despite support from NICE guidelines and guidance from NHS England. The ideal service needs to be easily accessible to patients with severe obesity, include a full multidisciplinary team with at least, medical, dietetic, psychology and physical activity expertise plus a surgical and anaesthetic team. Services need to provide an appropriate environment whether they are delivered in hospital or community settings and it is essential that they collect data in a format that can easily be audited. They should provide support for people with obesity for as long as they need it as time-limited services may be of limited value for a chronic disease that may progress and frequently relapses after treatment has stopped. Few, if any, services in the UK currently meet these standards.

Join us on the 7th December to hear John Wilding and an expert panel continue discussions surrounding obesity services.

This is a Novo Nordisk Sponsored meeting

Novo Nordisk has provided sponsorship to the Association of British Clinical Diabetologists (ABCD) to fully fund all costs for the development and delivery of this webinar, including creation, administration, promotion and speaker honoraria. Novo Nordisk has had no influence on the content and full editorial control remains the sole responsibility of ABCD.

On Demand URL

On Demand webinar: What should the ideal service for complex and severe obesity look like?

Speakers

Sally Abbott

Sally Abbott works both as an academic and as a clinical dietitian, specialising in obesity management. Sally is the Clinical Lead Dietitian for Tier 3 & Tier 4 services at University Hospitals Coventry & Warwickshire NHS Trust and Assistant Professor in Dietetics at Coventry University. She was the European winner of the IFSO (International Federation for the Surgery of Obesity) Integrated Health Scholarship in 2018 for her commitment to bariatric surgery dietetics and sits on national committees, including on the British Obesity and Metabolic Surgery Society (BOMSS) council and acting Bariatric Officer for the British Dietetic Association (BDA) Obesity Specialist Group. She is an EASO (European Association for Study of Obesity) National Clinical Fellow in recognition of her clinical expertise in the field.
Professor Rob Andrews

Rob Andrews is an associate Professor at the University of Exeter, an Honorary Consultant Physician at Musgrove Park Hospital Taunton.

At the University he leads a group that researches the role that exercise, and diet can play in the prevention and management of diabetes and Obesity. Ongoing studies include testing whether remote support can maintain activity in people with type 2 diabetes (MOTIVATE T2D); how apps can support weight loss in tier 3 clinics and which bariatric operation is best (ByBandSleeve). He is also leading on development of a Tier 3 Obesity database for the Society of Endocrinology.

In Taunton, Rob leads the Diabetes and Obesity Research team. Until last year he was the medical lead for a large multidisciplinary weight management service. This is a holistic service offering specialised dietary and exercise programs, drug therapy and bariatric surgery as well as running clinics for people with eating disorders and complications post surgery. In recognition of this service, Taunton is designated an International Centre of Excellence for Bariatric Surgery.
Professor Jennifer Logue

Jennifer Logue is Professor and Honorary Consultant in Metabolic Medicine, focusing both her research and clinical practice on the treatment of obesity and related metabolic disease. Her work focuses on interventions at the level of the individual with the aim of treating or preventing the complications of obesity. This includes interdisciplinary, mixed methods research to develop complex interventions, and pragmatic, efficient clinical trials utilising health record data. Her clinical work includes cardiovascular risk factor and weight management clinics. She is the Associate Dean for Research for the Faculty of Health and Medicine and Deputy Clinical Director of the NIHR North West Coast Clinical Research Network.
Professor ALEX MIRAS

Alex Miras is Professor of Endocrinology at Ulster University. His clinical and research work focus solely on Obesity and type 2 diabetes. He has contributed to the clinical management and research in Obesity over the last 14 years, through his work at a high throughput Obesity Centre. The specialist interests of his research Group are the mechanisms of action of interventions for obesity, focusing on pharmacotherapy, medical devices and obesity surgery.
Professor john andrew wass

Professor of Endocrinology, Oxford University
Head of the Department of Endocrinology at the Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital Oxford, until 2012.

Research interests: pituitary tumours, acromegaly, adrenal disease, angiogenesis in endocrinology, genetics of osteoporosis, thyroid disease.

Chair RCP Group on Weight and Health . Spokesperson on Obesity Royal College of Physicians

Published over 440 articles, edited different textbooks; Oxford Textbook of Endocrinology (3 editions), Clinical Endocrine Oncology (2 editions), Oxford Handbook of Endocrinology (4 editions)

President European Federation of Endocrine Societies from 2001-2003
Chairman Society for Endocrinology 2006-2009
President American Pituitary Society.

Awards

Outstanding Leadership Award, American Endocrine Society 2022

Outstanding Scholarly Physician Award, American Endocrine Society 2016 (first non-American)

Lifetime Achievement Award, Pituitary Society (America) 2017

Geoffrey Harris Prize European Society of Endocrinology 2021

Academic Vice President Royal College of Physicians 2012-2015.

Presented acclaimed documentary ‘The Fantastical World of Hormones’ on BBC4, 2016

Current Getting It Right First Time Endocrine Lead, NHS England, visiting and inspecting all endocrine departments in the UK (127) and doing a national report.
Professor John Wilding

Professor John Wilding leads clinical research into Obesity, Diabetes and Endocrinology at the University of Liverpool, where he has worked since 1996, after training in Southampton and London. His clinical interests focus on caring for people with diabetes and obesity and he leads specialist services for obesity at Aintree University Hospital – designated a Centre for Obesity Management by the European Association for the Study of Obesity.
John’s research team focusses on developing and evaluating treatments for obesity and diabetes. He has published over 350 papers, chapters and review articles, including clinical trials in diabetes and obesity, studies of adipocyte biology and metabolism.
He chairs the National Clinical Research Network Metabolic and Endocrine Speciality Group.
He is a past Chair of the UK Association for the Study of Obesity, a member of the Royal College of Physicians Advisory Group on Nutrition, Weight and Health and past President of the World Obesity Federation.